國立虎尾科技大學 |

Re-irradiation = new fronter /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Re-irradiation/ edited by Carsten Nieder, Johannes Langendijk.
其他題名:	new fronter /
其他作者:	Nieder, Carsten.
出版者:	Cham :Springer International Publishing : : 2017.,
面頁冊數:	x, 364 p. :ill., digital ; : 24 cm.;
Contained By:	Springer eBooks
標題:	Radiotherapy. -
電子資源:	http://dx.doi.org/10.1007/978-3-319-41825-4
ISBN:	9783319418254

Re-irradiation = new fronter /
Re-irradiationnew fronter /[electronic resource] :edited by Carsten Nieder, Johannes Langendijk. - 2nd ed. - Cham :Springer International Publishing :2017. - x, 364 p. :ill., digital ;24 cm. - Medical radiology,0942-5373. - Medical radiology..

Normal Tissue Tolerance to Reirradiation -- Fractionation Concepts -- Hyperthermia and Reirradiation -- Therapeutic Ratio of Reirradiation with Cytotoxic Drugs and Other Response-Modifying Agents -- Reduced Normal Tissue Doses Through Advanced Technology -- Brain Tumors -- Eye Tumors -- Head and Neck Cancer: Nasopharynx -- Head and Neck Cancer: other Sites -- Lung Cancer -- Breast Cancer -- Prostate Cancer -- Rectal Cancer -- Gynaecological Malignancies -- Soft Tissue Sarcomas -- Bone Metastases -- Brain Metastases -- Skin Cancer -- Pancreatic Cancer Esophageal Cancer -- Lymphoma.

This book, now in its second edition, provides a comprehensive overview of current re-irradiation strategies, with detailed discussion of re-irradiation methods, technical aspects, the role of combined therapy with anticancer drugs and hyperthermia, and normal tissue tolerance. In addition, disease specific chapters document recent clinical results and future research directions. All chapters from the first edition have been revised and updated to take account of the latest developments and research findings, including those from prospective studies. Due attention is paid to the exciting developments in the fields of proton irradiation and frameless image-guided ablative radiotherapy. The book documents fully how refined combined modality approaches and significant technical advances in radiation treatment planning and delivery have facilitated the re-irradiation of previously exposed volumes, allowing both palliative and curative approaches to be pursued at various disease sites. Professionals involved in radiation treatment planning and multimodal oncology treatment will find it to be an invaluable aid in understanding the benefits and limitations of re-irradiation and in designing prospective trials.

ISBN: 9783319418254

Standard No.: 10.1007/978-3-319-41825-4doiSubjects--Topical Terms:

593952
Radiotherapy.

LC Class. No.: RM847

Dewey Class. No.: 615.842

Re-irradiation = new fronter /
LDR:02796nam a2200337 a 4500 001 956918
003 DE-He213
005 20161025133829.0
006 m d
007 cr nn 008maaau
008 201118s2017 gw s 0 eng d
020 $a 9783319418254 $q (electronic bk.)
020 $a 9783319418230 $q (paper)
024 7 $a 10.1007/978-3-319-41825-4 $2 doi
035 $a 978-3-319-41825-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RM847
072 7 $a MJCL1 $2 bicssc
072 7 $a MED080000 $2 bisacsh
082 0 4 $a 615.842 $2 23
090 $a RM847 $b .R281 2017
245 0 0 $a Re-irradiation $h [electronic resource] : $b new fronter / $c edited by Carsten Nieder, Johannes Langendijk.
250 $a 2nd ed.
260 $a Cham : $c 2017. $b Springer International Publishing : $b Imprint: Springer,
300 $a x, 364 p. : $b ill., digital ; $c 24 cm.
490 1 $a Medical radiology, $x 0942-5373
505 0 $a Normal Tissue Tolerance to Reirradiation -- Fractionation Concepts -- Hyperthermia and Reirradiation -- Therapeutic Ratio of Reirradiation with Cytotoxic Drugs and Other Response-Modifying Agents -- Reduced Normal Tissue Doses Through Advanced Technology -- Brain Tumors -- Eye Tumors -- Head and Neck Cancer: Nasopharynx -- Head and Neck Cancer: other Sites -- Lung Cancer -- Breast Cancer -- Prostate Cancer -- Rectal Cancer -- Gynaecological Malignancies -- Soft Tissue Sarcomas -- Bone Metastases -- Brain Metastases -- Skin Cancer -- Pancreatic Cancer Esophageal Cancer -- Lymphoma.
520 $a This book, now in its second edition, provides a comprehensive overview of current re-irradiation strategies, with detailed discussion of re-irradiation methods, technical aspects, the role of combined therapy with anticancer drugs and hyperthermia, and normal tissue tolerance. In addition, disease specific chapters document recent clinical results and future research directions. All chapters from the first edition have been revised and updated to take account of the latest developments and research findings, including those from prospective studies. Due attention is paid to the exciting developments in the fields of proton irradiation and frameless image-guided ablative radiotherapy. The book documents fully how refined combined modality approaches and significant technical advances in radiation treatment planning and delivery have facilitated the re-irradiation of previously exposed volumes, allowing both palliative and curative approaches to be pursued at various disease sites. Professionals involved in radiation treatment planning and multimodal oncology treatment will find it to be an invaluable aid in understanding the benefits and limitations of re-irradiation and in designing prospective trials.
650 0 $a Radiotherapy. $3 593952
650 1 4 $a Medicine & Public Health. $3 593949
650 2 4 $a Oncology. $3 593951
700 1 $a Nieder, Carsten. $3 785529
700 1 $a Langendijk, Johannes. $3 1248255
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
830 0 $a Medical radiology. $3 680197
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-41825-4
950 $a Medicine (Springer-11650)